Related Experiment Videos
[Tumor-correlated asthenia].
Marcello Tavio1, Isabella Milan, Umberto Tirelli
1Divisione di Oncologia Medica A, Centro di Riferimento Oncologico, Aviano.
Recenti Progressi in Medicina
|December 20, 2002
Summary
Cancer-related fatigue is a persistent tiredness affecting most patients during and after treatment, often disproportionate to activity and unrelieved by rest. Its causes remain unknown, with no standard assessment or treatment protocols currently established.
Area of Science:
- Oncology
- Patient Experience
- Symptom Management
Context:
- Fatigue is a prevalent and debilitating symptom in cancer patients, impacting those undergoing active treatment and survivors.
- This chronic tiredness is distinct from normal fatigue, characterized by being unusual, disproportionate to exertion, and unrelieved by rest.
Purpose:
- To review critical issues surrounding cancer-related fatigue (CRF).
- To highlight the lack of standardized assessment and treatment protocols for CRF.
- To discuss the multidimensional nature of CRF evaluation and current treatment approaches.
Summary:
- Cancer-related fatigue (CRF) is a common, persistent symptom affecting a majority of cancer patients during therapy and a significant number of survivors.
- The exact etiology of CRF is unknown, and current management often targets associated symptoms rather than fatigue itself.
- Existing evaluation methods for CRF are multidimensional, yet a standardized approach to assessment and treatment is lacking.
Impact:
- Addresses a significant unmet need in cancer care by reviewing the complexities of fatigue management.
- Provides a foundation for future research into the causes and effective treatments for cancer-related fatigue.
- Aims to improve the quality of life for cancer patients and survivors by highlighting critical issues in fatigue symptom management.